FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016480908> ?p ?o ?g. }

• W2016480908 endingPage "205" @default.
• W2016480908 startingPage "198" @default.
• W2016480908 abstract "Aims The aims of this study were to investigate whether endogenous steroid hormones are (1) related to pathogenesis of stress urinary incontinence after menopause, (2) are related to severity of stress urinary incontinence, and (3) are related to prognostic parameters of stress urinary incontinence. Methods Twenty post-partum women with clinically diagnosed stress urinary incontinence and 20 age-matched postmenopausal women without stress urinary incontinence (control group) were evaluated. We compared urinary profile of the endogenous steroid hormones patients with stress urinary incontinence and controls, and between grade I and grade II of stress urinary incontinence. We also in vestigated the relationship between urinary profile of the endogenous steroid hormones and prognostic parameters of stress urinary incontinence (maximal urethral closure pressure, functional urethral length, Valsalva leak point pressure, cough leak point pressure, posterior urethrovesical angle, bladder neck descent, and stress urethral axis). The ages of the patients and those in the control group were 64.3 ± 5.6 and 57.5 ± 3.8 years old and the body mass indexes were 24.96 ± 3.14 and 22.11 ± 2.73 kg/m2 in patients and in normal subjects, respectively. Nine patients were grade I and 11 were grade II. Estrone and 17β-estradiol only were detected in all subjects, regardless of control or patient group. It is noteworthy that there were no significant differ ences (P > 0.05) in the levels of estrone and 17β-estradiol in the urine of postmenopausal normal subjects compared with in the urine of postmenopausal patients with urinary incontinence. E2/E1 ratio was not different between the two groups (P > 0.05). Among the objective steroids, DHEA, Δ4-dione, Δ5-diol, Te, DHT, 16α-DHT, 11-keto An, THDOC, and THB were not detected either in the urine of normal subjects and nor in the urine of the patients. After comparing androgen levels between normal subjects and patients, no significant differences (P>0.05) were detected, except for 5α-THB and 5α-THF. Neither 5α-THB or 5α-THF were detected in the patients' urine. Et/An (11β-OH Et/11β-OH An) concentration ratios were not significantly different between the two groups, either (P > 0.05). There were not significant differences of concentrations (μmol/g creatinine) of urinary steroids between grade I and grade II of stress urinary incontinence. Pregnanediol was significantly related to bladder neck descent in supine and sitting positions (R = 0.79, P = 0.01, and R = 0.73, P = 0.03, respectively), and pregnanetriol was significantly related to maximal urethral closure pressure and functional urethral length (R = 0.68, P = 0.04, and R = −0.79, P = 0.01, respectively). Androsterone was significantly related to bladder neck descent in supine and sitting positions (R = 0.68, P = 0.04, and R = 0.78, P = 0.01, respectively). 5-AT was significantly related to bladder neck descent in sitting position and stress urethral axis (R = 0.72, P = 0.03, and R = −0.71, P = 0.03). 11-Keto Et was significantly related to bladder neck descent in supine and sitting positions and related to stress ure thral axis (R = 0.82, P = 0.01, and R = 0.81, P = 0.01, R = −0.67, P = 0.04, respectively). THS was signi ficantly related to bladder neck descent in supine and sitting positions and related to stress urethral axis (R = 0.76, P = 0.02, and R = 0.74, P = 0.02, R = −0.68, P = 0.04, respectively). THE was significantly related to bladder neck descent in sitting position (R = 0.67, P = 0.04).β-Tetrahydrocortisol/α-tetrahydrocortisol (β-THF/α-THF) and α-cortol were significantly related to maximal urethral closure pressure and functional urethral length (R = 0.74, P = 0.02, and R = −0.92, P = 0.01; R = 0.71, P = 0.36, and R = −0.87, P = 0.000, respectively). 17β-Estradiol (E2) was significantly related to bladder neck descent in supine position (R = −0.62, P = 0.04) and 17β-estradiol/estrone (E2/E1) was significantly related to cough leak point pressure (R = 0.79, P = 0.01). In conclusion, the urinary concentrations of endogenous steroid metabolites in postmenopausal patients with stress urinary incontinence were not significantly different from normal patients and were not significantly different between grade I and grade II patients with stress urinary incontinence. Some endogenous steroid metabolites were positively or negatively significantly related to prognostic parameters of stress urinary incontinence. Neurourol. Urodynam. 22:198–205, 2003. © 2003 Wiley-Liss, Inc." @default.
• W2016480908 created "2016-06-24" @default.
• W2016480908 creator A5023982339 @default.
• W2016480908 creator A5030364185 @default.
• W2016480908 creator A5038222480 @default.
• W2016480908 creator A5042364551 @default.
• W2016480908 creator A5062423494 @default.
• W2016480908 creator A5080064863 @default.
• W2016480908 creator A5084269680 @default.
• W2016480908 creator A5085600530 @default.
• W2016480908 creator A5086182270 @default.
• W2016480908 date "2003-01-01" @default.
• W2016480908 modified "2023-10-10" @default.
• W2016480908 title "Relationship between urinary profile of the endogenous steroids and postmenopausal women with stress urinary incontinence" @default.
• W2016480908 cites W1485329507 @default.
• W2016480908 cites W1673648816 @default.
• W2016480908 cites W1967711385 @default.
• W2016480908 cites W1977163463 @default.
• W2016480908 cites W1978283734 @default.
• W2016480908 cites W1981012897 @default.
• W2016480908 cites W1982125384 @default.
• W2016480908 cites W1988229292 @default.
• W2016480908 cites W1989292079 @default.
• W2016480908 cites W1992163849 @default.
• W2016480908 cites W1997658972 @default.
• W2016480908 cites W2005284147 @default.
• W2016480908 cites W2007192161 @default.
• W2016480908 cites W2011481382 @default.
• W2016480908 cites W2012291650 @default.
• W2016480908 cites W2018910265 @default.
• W2016480908 cites W2024053508 @default.
• W2016480908 cites W2024679235 @default.
• W2016480908 cites W2029447634 @default.
• W2016480908 cites W2031184539 @default.
• W2016480908 cites W2033459779 @default.
• W2016480908 cites W2048647054 @default.
• W2016480908 cites W2052961173 @default.
• W2016480908 cites W2065894976 @default.
• W2016480908 cites W2066187903 @default.
• W2016480908 cites W2074182011 @default.
• W2016480908 cites W2076761940 @default.
• W2016480908 cites W2092574244 @default.
• W2016480908 cites W2151146488 @default.
• W2016480908 cites W2404187994 @default.
• W2016480908 cites W2406467335 @default.
• W2016480908 cites W2416334241 @default.
• W2016480908 doi "https://doi.org/10.1002/nau.10063" @default.
• W2016480908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12707870" @default.
• W2016480908 hasPublicationYear "2003" @default.
• W2016480908 type Work @default.
• W2016480908 sameAs 2016480908 @default.
• W2016480908 citedByCount "19" @default.
• W2016480908 countsByYear W20164809082013 @default.
• W2016480908 countsByYear W20164809082014 @default.
• W2016480908 countsByYear W20164809082015 @default.
• W2016480908 countsByYear W20164809082018 @default.
• W2016480908 crossrefType "journal-article" @default.
• W2016480908 hasAuthorship W2016480908A5023982339 @default.
• W2016480908 hasAuthorship W2016480908A5030364185 @default.
• W2016480908 hasAuthorship W2016480908A5038222480 @default.
• W2016480908 hasAuthorship W2016480908A5042364551 @default.
• W2016480908 hasAuthorship W2016480908A5062423494 @default.
• W2016480908 hasAuthorship W2016480908A5080064863 @default.
• W2016480908 hasAuthorship W2016480908A5084269680 @default.
• W2016480908 hasAuthorship W2016480908A5085600530 @default.
• W2016480908 hasAuthorship W2016480908A5086182270 @default.
• W2016480908 hasConcept C126322002 @default.
• W2016480908 hasConcept C126894567 @default.
• W2016480908 hasConcept C2778531004 @default.
• W2016480908 hasConcept C2778562196 @default.
• W2016480908 hasConcept C2778656385 @default.
• W2016480908 hasConcept C2779523193 @default.
• W2016480908 hasConcept C2780026642 @default.
• W2016480908 hasConcept C71315377 @default.
• W2016480908 hasConcept C71924100 @default.
• W2016480908 hasConcept C77411442 @default.
• W2016480908 hasConceptScore W2016480908C126322002 @default.
• W2016480908 hasConceptScore W2016480908C126894567 @default.
• W2016480908 hasConceptScore W2016480908C2778531004 @default.
• W2016480908 hasConceptScore W2016480908C2778562196 @default.
• W2016480908 hasConceptScore W2016480908C2778656385 @default.
• W2016480908 hasConceptScore W2016480908C2779523193 @default.
• W2016480908 hasConceptScore W2016480908C2780026642 @default.
• W2016480908 hasConceptScore W2016480908C71315377 @default.
• W2016480908 hasConceptScore W2016480908C71924100 @default.
• W2016480908 hasConceptScore W2016480908C77411442 @default.
• W2016480908 hasIssue "3" @default.
• W2016480908 hasLocation W20164809081 @default.
• W2016480908 hasLocation W20164809082 @default.
• W2016480908 hasOpenAccess W2016480908 @default.
• W2016480908 hasPrimaryLocation W20164809081 @default.
• W2016480908 hasRelatedWork W1980292270 @default.
• W2016480908 hasRelatedWork W2003063668 @default.
• W2016480908 hasRelatedWork W2016480908 @default.
• W2016480908 hasRelatedWork W2089101181 @default.
• W2016480908 hasRelatedWork W2120561004 @default.
• W2016480908 hasRelatedWork W2387958031 @default.
• W2016480908 hasRelatedWork W2411535423 @default.

• next